taupositive

Taupositive refers to the presence of abnormally phosphorylated tau protein in biological samples, most commonly in brain tissue or cerebrospinal fluid. This phosphorylation is a key pathological hallmark of several neurodegenerative diseases, collectively known as tauopathies. In healthy individuals, tau protein plays a crucial role in stabilizing microtubules, which are essential components of neurons. However, in tauopathies, tau becomes hyperphosphorylated, detaches from microtubules, and aggregates into neurofibrillary tangles (NFTs). These tangles disrupt neuronal function and contribute to cell death.

Detecting taupositive material is a significant diagnostic tool. Post-mortem examination of brain tissue definitively identifies NFTs. In living patients, taupositive biomarkers are measured in cerebrospinal fluid (CSF) using techniques like ELISA. Elevated levels of specific tau species, such as total tau, phosphorylated tau (p-tau), and abnormal tau aggregates, in CSF are indicative of underlying tau pathology. These CSF biomarkers are particularly useful in the diagnosis and monitoring of Alzheimer's disease, where tau pathology is a prominent feature alongside amyloid plaques. Research is also ongoing to develop PET imaging tracers that can detect tau aggregates in the living brain. The presence and distribution of taupositive aggregates correlate with disease severity and progression.